Kcnq potassium channels and methods of modulating same
CA 2300985 A1 · Owner: Yang, Wen-Pin · Inventors: Gribkoff, Valentin K.; Yang, Wen-Pin; Levesque, Paul C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to KCNQ proteins defining potassium channels. In particular, the invention concerns the human KCNQ2 human KCNQ3, murine KCNQ2, and rat KCNQ2 proteins reported herein. KCNQ2 and KCNQ3 proteins are nervous system-selective and may be involved in neurotransmission and neuroprotection. The KCNQ2 and KCNQ3 of the present invention can be used to assay for modulators of the proteins, which would be useful in treatment of such disorders as ataxia, myokymia, seizures Alzheimer's disease, Parkinson's , disease age-associated memory loss, learning deficiencies motor neuron , diseases, epilepsy, stroke and the like.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 26, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 26, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 26, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.